Grail Inc (GRAL)

Currency in USD
54.06
-0.42(-0.77%)
Closed·
53.99-0.07(-0.13%)
·
GRAL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
52.1954.63
52 wk Range
29.95118.84
Key Statistics
Prev. Close
54.48
Open
54.03
Day's Range
52.19-54.63
52 wk Range
29.95-118.84
Volume
502.51K
Average Vol. (3m)
1.23M
1-Year Change
51.1111%
Book Value / Share
66.13
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GRAL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
67.71
Upside
+25.26%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period

Grail Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

4 Buy
4 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 67.71
(+25.26% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Mizuho
Hold58.00+7.29%-New CoverageApr 10, 2026
Piper Sandler
Hold54.00-0.11%-New CoverageApr 10, 2026
Guggenheim
Buy75.00+38.73%130.00MaintainMar 30, 2026
Guggenheim
Buy130.00+140.47%-MaintainMar 23, 2026
TD Cowen
Buy65.00+20.24%114.00UpgradeMar 18, 2026

Grail Inc Earnings Call Summary for Q3/2025

  • Grail reported Q3 2025 revenue of $36.2 million, up 26% YoY, with improved non-GAAP gross margin of 55%, despite a net loss of $89 million; stock surged 6.01% after hours.
  • The company sold 420,000 commercial Galleri tests through 16,000 healthcare providers, with US Galleri revenue increasing 28% to $32.6 million.
  • Strategic partnerships, including one with Samsung, aim to enhance Grail's market position in Asia as the company explores direct-to-consumer and digital health channels.
  • Grail plans FDA submission in Q1 2026, expects NHS-Galleri results mid-2026, and projects US Galleri revenue growth in the middle of the 20-30% range.
  • Management extended cash runway projections into 2030, enabling the company to achieve planned clinical and regulatory milestones while improving operational efficiency.
Last Updated: 11/12/2025, 05:24 PM
Read Full Transcript

Earnings

Latest Release
Feb 19, 2026
EPS / Forecast
-2.44 / -4.01
Revenue / Forecast
43.6M / --
EPS Revisions
Last 90 days

GRAL Income Statement

Compare GRAL to Peers and Sector

Metrics to compare
GRAL
Peers
Sector
Relationship
P/E Ratio
−5.4x−5.1x−0.5x
PEG Ratio
−0.07−0.200.00
Price / Book
0.9x1.9x2.6x
Price / LTM Sales
15.1x10.2x3.2x
Upside (Analyst Target)
20.2%70.2%48.1%
Fair Value Upside
Unlock−14.9%6.6%Unlock

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.38M25.30%560.96M
Other Institutional Investors
25.48M62.12%1.38B
Public Companies & Retail Investors
5.16M12.59%279.11M
Total
41.02M100.00%2.22B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.7.21%2,958,121159,916
Farallon Capital Management, L.L.C.5.71%2,342,684126,645

People Also Watch

36.900
PL
-0.19%
949.93
LITE
+5.28%
11.230
RCAT
-4.18%
10.320
ONDS
+2.79%
1,187.00
SNDK
+8.25%

FAQ

What Is the Grail (GRAL) Stock Price Today?

The Grail stock price today is 54.06 USD.

What Stock Exchange Does Grail Trade On?

Grail is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Grail?

The stock symbol for Grail is "GRAL."

What Is the Grail Market Cap?

As of today, Grail market cap is 2.22B USD.

What Is Grail's Earnings Per Share (TTM)?

The Grail EPS (TTM) is -11.11.

When Is the Next Grail Earnings Date?

Grail will release its next earnings report on May 05, 2026.

From a Technical Analysis Perspective, Is GRAL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Grail Stock Split?

Grail has split 0 times.

How Many Employees Does Grail Have?

Grail has 910 employees.

What is the current trading status of Grail (GRAL)?

As of May 03, 2026, Grail (GRAL) is trading at a price of 54.06 USD, with a previous close of 54.48 USD. The stock has fluctuated within a day range of 52.19 USD to 54.63 USD, while its 52-week range spans from 29.95 USD to 118.84 USD.

What Is Grail (GRAL) Price Target According to Analysts?

The average 12-month price target for Grail is 67.71 USD, with a high estimate of 82 USD and a low estimate of 54 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +25.26% Upside potential.

What Is the GRAL Premarket Price?

GRAL's last pre-market stock price is 54.04 USD. The pre-market share volume is 301.00, and the stock has decreased by -0.44, or -0.81%.

What Is the GRAL After Hours Price?

GRAL's last after hours stock price is 53.99 USD, the stock has decreased by -0.07, or -0.13%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.